Takashi Taga
0000-0003-0525-4766
6 papers found
Refreshing results…
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia
Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome
Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome
Attempts to optimize postinduction treatment in childhood acute myeloid leukemia without core‐binding factors: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan
Missing publications? Search for publications with a matching author name.